The Latest Breaking News from FDA

Toxic metal can be harmful to developing brains. New lead targets are part of a broad FDA imitative to reduce children's exposure to the lowest levels possible.

Money and lobbying help shield lab-developed tests, including prenatal screenings, from heightened federal scrutiny

A treatment that improves Alzheimer’s disease would be a great advance, but Leqembi (lecanemab), which recently received accelerated approval from the FDA, is not that drug. Yes, lecanemab slows decline to an extent detectable on a test, but not to an extent that a relative or caretaker would notice. This…

An independent investigation into logging in the Liberian rainforest found illegal operations “on a significant scale,” with multiple missteps or breaches of law by the government agency charged with protecting those forests

Americans will get a clearer idea of how often they’ll roll up their sleeves for COVID-19 shots when advisers to U.S. regulators meet Thursday to discuss an immunization schedule that looks more like the one used for flu.

The virus has not yet fully settled into a pattern of seasonality and may never, experts caution.

Questions have been raised about how Australia ensures the quality of its imported medicines after a major pharmaceutical company was warned over lapses in contamination control and manufacturing practices.

U.S. health officials want to make COVID-19 vaccinations more like the annual flu shot

A class action lawsuit has set its sights on a popular Coca-Cola juice brand.

With rising global medical requirements and continuous technological advancements, the healthcare industry is poised to remain buoyed in the near term. Therefore, quality medical stocks Abbott Laboratories (ABT) and Varex Imaging (VREX) might be solid buys before January ends. However, avoiding fundamentally weak stock SmileDirectClub (SDC) could be wise. Read…

The new approach would simplify vaccination guidance so that, every fall, people would get a new shot, updated to try to match whatever variant is dominant.